We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
IVX.AU

Price
0.09
Stock movement up
+- (0.00%)
Company name
Invion Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
7.88M
Ent value
8.27M
Price/Sales
2.13
Price/Book
0.95
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
43.62%
1 year return
-65.28%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-12-12

DIVIDENDS

IVX.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales2.13
Price to Book0.95
EV to Sales2.24

FINANCIALS

Per share

Per share data
Current share count85.65M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash850.37K
Net receivables0.00
Total current assets933.20K
Goodwill0.00
Intangible assets8.54M
Property, plant and equipment20.52K
Total assets9.49M
Accounts payable542.80K
Short/Current long term debt0.00
Total current liabilities1.24M
Total liabilities1.24M
Shareholder's equity8.25M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Stock price data
Open0.09
Daily high0.09
Daily low0.09
Daily Volume227K
All-time high54.56
1y analyst estimate0.11
Beta0.77
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date26 Feb 2026

Downside potential

Downside potential data
IVX.AUS&P500
Current price drop from All-time high-99.83%-1.08%
Highest price drop-99.86%-19.00%
Date of highest drop19 Nov 20258 Apr 2025
Avg drop from high-99.74%-2.64%
Avg time to new high-6 days
Max time to new high300 days89 days
COMPANY DETAILS
IVX.AU (Invion Ltd) company logo
Marketcap
7.88M
Marketcap category
Small-cap
Description
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Employees
0
Website
https://www.inviongroup.com
Investor relations
-
SEC filings
IVX.AU SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesFeatured ArticlesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved